Skip to main content
Fig. 10 | Biological Research

Fig. 10

From: Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models

Fig. 10

(A) Triple immunostaining at 40x magnification for Iba1, TH and GFAP, nuclei were counterstained with DAPI. On the left, it is possible to appreciate 20x magnification, while on the right higher magnification for TH, Iba1 and GFAP staining and merge figures were shown. (B) Histograms for GFAP and Iba1 show the fluorescence intensity, as % of controls. (C) Western blotting and relative densitometric analysis for mBDNF, pCREB and pAKT in the striatum and substantia nigra *** p < 0.0005; ** p < 0.005; * p < 0.05 vs. CTR; +++ p < 0.0005, ++ p < 0.005 vs. 6-OHDA.

Back to article page